Paroxysmal Tonic Gaze Vertical Gaze Phenomena of infancy

see also: Paroxymsal Tonic DownGaze

Below is the response formatted in DokuWiki syntax. Since source URLs were not provided in the retrieved citations, the link targets are left as placeholders for insertion.

  • Benign (paroxysmal) tonic upgaze and paroxysmal tonic downgaze of infancy are two distinct entities
  • Defined by opposite directions of vertical eye deviation and by different clinical courses, associations, and workup implications.

Benign (paroxysmal) tonic upgaze (PTU)

  • Characterized by episodes of sustained conjugate upward deviation of the eyes, with compensatory neck flexion (chin-down posture) and incomplete/down-beating saccades on attempted downgaze; horizontal eye movements are normal and consciousness is preserved.
  • Onset is typically within the first year (mean age of onset ~5–6 months, though reported from the first week to age 7).
  • Features include diurnal fluctuation, relief with sleep, exacerbation by febrile illness/fatigue, and frequently associated ataxia.
  • Historically considered benign with eventual resolution, but the label is misleading: substantial proportions have developmental delay, cognitive dysfunction, or abnormal neurological findings, and it is increasingly recognized as part of a neurodevelopmental spectrum with identified genetic bases, especially CACNA1A (also KCNA1, FGF14, GRID2). One acetazolamide-responsive form is CACNA1A-related.

Paroxysmal tonic downgaze of infancy

  • Characterized by tonic downward deviation of the eyes (often slightly exotropic), with intermittent upward saccades — the mirror image of PTU. Also described as “benign positional vertical opsoclonus,” often occurring in the supine position.
  • An idiopathic/benign form occurs in term infants, presents very early (days to ~12 weeks), and resolves spontaneously (often by ~6 months) with normal development and neuroimaging; a comprehensive workup may be unnecessary in classic benign cases.
  • However, symptomatic tonic downgaze is strongly associated with CNS injury — particularly periventricular leukomalacia and hypoxic-ischemic injury in preterm infants, correlating with subcortical visual loss, spastic diplegia/quadriplegia, and developmental delay. It can also be the presenting sign of serious treatable disease (e.g., biotin-thiamine-responsive basal ganglia disease, so context-dependent evaluation is essential.

Key distinctions

Feature Benign tonic upgaze (PTU) Tonic downgaze of infancy
Eye deviation Sustained upward, with chin-down neck flexion Sustained downward, often exotropic/supine-triggered
Saccade correction Down-beating saccades on attempted downgaze Intermittent upward saccades
Typical onset First year, mean ~5–6 mo Very early (days–12 wk) in benign form
Prognosis/associations Often part of neurodevelopmental spectrum; CACNA1A and other genes Benign form resolves; symptomatic form linked to PVL/HIE, metabolic disease

Both are on the differential of nonepileptic paroxysmal eye-movement phenomena of infancy and can be mistaken for seizures, so video documentation and normal EEG during events are useful in distinguishing them from epilepsy.